Diabetic Eye Disease
Bibliographic References tagged with Diabetic Eye Disease
Not finding what you're looking for? Try using Advanced Search.
Not finding what you're looking for? Try using Advanced Search.
Weng C, Maguire M, Flaxel C, Jain N, Kim S, Patel S, Smith J, Kim L, Yeh S. Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
Ophthalmology. 2024; PMID: 38613533
Weng C, Maguire M, Flaxel C, Jain N, Kim S, Patel S, Smith J, Kim L, Yeh S. Effectiveness of Conventional Digital Fundus Photography-Based Teleretinal Screening for Diabetic Retinopathy and Diabetic Macular Edema: A Report by the American Academy of Ophthalmology.
Ophthalmology. 2024; PMID: 38613533
Ntentakis DP, Corrêa VSMC, Ntentaki AM, Vavvas DG. Differences in effects of some newer-generation anti-diabetics on diabetic retinopathy versus nephropathy.
Graefes Arch Clin Exp Ophthalmol. 2024;262(4):1371–1372. PMID: 38197991
Ntentakis DP, Corrêa VSMC, Ntentaki AM, Vavvas DG. Differences in effects of some newer-generation anti-diabetics on diabetic retinopathy versus nephropathy.
Graefes Arch Clin Exp Ophthalmol. 2024;262(4):1371–1372. PMID: 38197991
Gonzalez-Perez J, Lopera-Echavarría, Arevalo-Alquichire S, Araque-Marín P, Londoño M. Development of a Resveratrol Nanoformulation for the Treatment of Diabetic Retinopathy.
Materials (Basel). 2024;17(6). PMID: 38541574
Gonzalez-Perez J, Lopera-Echavarría, Arevalo-Alquichire S, Araque-Marín P, Londoño M. Development of a Resveratrol Nanoformulation for the Treatment of Diabetic Retinopathy.
Materials (Basel). 2024;17(6). PMID: 38541574
Rauscher F, Elze T, Francke M, Martinez-Perez E, Li Y, Wirkner K, Tönjes A, Engel C, Thiery J, Blüher M, Stumvoll M, Kirsten T, Loeffler M, Ebert T, Wang M. Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
Diabetologia. 2024;67(5):928–939. PMID: 38431705
Rauscher F, Elze T, Francke M, Martinez-Perez E, Li Y, Wirkner K, Tönjes A, Engel C, Thiery J, Blüher M, Stumvoll M, Kirsten T, Loeffler M, Ebert T, Wang M. Glucose tolerance and insulin resistance/sensitivity associate with retinal layer characteristics: the LIFE-Adult-Study.
Diabetologia. 2024;67(5):928–939. PMID: 38431705
Silva P, Zhang D, Jacoba CM, Fickweiler W, Lewis D, Leitmeyer J, Curran K, Salongcay R, Doan D, Ashraf M, Cavallerano J, Sun J, Peto T, Aiello LP. Automated Machine Learning for Predicting Diabetic Retinopathy Progression From Ultra-Widefield Retinal Images.
JAMA Ophthalmol. 2024;142(3):171–177. PMID: 38329765
Silva P, Zhang D, Jacoba CM, Fickweiler W, Lewis D, Leitmeyer J, Curran K, Salongcay R, Doan D, Ashraf M, Cavallerano J, Sun J, Peto T, Aiello LP. Automated Machine Learning for Predicting Diabetic Retinopathy Progression From Ultra-Widefield Retinal Images.
JAMA Ophthalmol. 2024;142(3):171–177. PMID: 38329765
Vujosevic S, Fantaguzzi F, Silva P, Salongcay R, Brambilla M, Torti E, Nucci P, Peto T. Macula vs periphery in diabetic retinopathy: OCT-angiography and ultrawide field fluorescein angiography imaging of retinal non perfusion.
Eye (Lond). 2024; PMID: 38402286
Vujosevic S, Fantaguzzi F, Silva P, Salongcay R, Brambilla M, Torti E, Nucci P, Peto T. Macula vs periphery in diabetic retinopathy: OCT-angiography and ultrawide field fluorescein angiography imaging of retinal non perfusion.
Eye (Lond). 2024; PMID: 38402286
Writing Committee, Jhaveri C, Liu D, Maguire M, Glassman A, Grigorian R, Jampol L, Kingsley R, MacCumber M, Martin D, Maturi R, Velez G, Sun J, DRCR Retina Network. Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity.
Ophthalmology. 2024; PMID: 38336282
Writing Committee, Jhaveri C, Liu D, Maguire M, Glassman A, Grigorian R, Jampol L, Kingsley R, MacCumber M, Martin D, Maturi R, Velez G, Sun J, DRCR Retina Network. Risk Factors for Meeting Criteria for Switching from Bevacizumab to Aflibercept When Treating Eyes with Diabetic Macular Edema and Visual Acuity.
Ophthalmology. 2024; PMID: 38336282
Levine R, Myers M, Barunas R, Chang D, Dutta S, Maddess T, Liebmann J, Sherman S, Eydelman M, Sun J, Chambers W, Wickström K, Luhmann U, Pallinat M, Glassman A, Aiello LP, Markel D, Gardner T. Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.
Transl Vis Sci Technol. 2023;12(11):33. PMID: 38015167
Levine R, Myers M, Barunas R, Chang D, Dutta S, Maddess T, Liebmann J, Sherman S, Eydelman M, Sun J, Chambers W, Wickström K, Luhmann U, Pallinat M, Glassman A, Aiello LP, Markel D, Gardner T. Report From the 2022 Mary Tyler Moore Vision Initiative Diabetic Retinal Disease Clinical Endpoints Workshop.
Transl Vis Sci Technol. 2023;12(11):33. PMID: 38015167
Zang B, Rong SS, Wang Y, Feng KM, Ding XX, Wen L, Zang D, Li D, Liang YB, Wang FH, Zhai G. ASSOCIATION OF DIABETIC MACULAR EDEMA WITH QUALITY OF LIFE IN PATIENTS WITH TYPE 2 DIABETES: The Fushun Diabetic Retinopathy Cohort Study.
Retina. 2024;44(3):537–544. PMID: 37972959
Zang B, Rong SS, Wang Y, Feng KM, Ding XX, Wen L, Zang D, Li D, Liang YB, Wang FH, Zhai G. ASSOCIATION OF DIABETIC MACULAR EDEMA WITH QUALITY OF LIFE IN PATIENTS WITH TYPE 2 DIABETES: The Fushun Diabetic Retinopathy Cohort Study.
Retina. 2024;44(3):537–544. PMID: 37972959
Aiello LP, Jacoba CM, Ashraf M, Cavallerano J, Tolson A, Tolls D, Sun J, Silva P. INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE.
Retina. 2023;43(11):1928–1935. PMID: 37871272
Aiello LP, Jacoba CM, Ashraf M, Cavallerano J, Tolson A, Tolls D, Sun J, Silva P. INTEGRATING MACULAR OPTICAL COHERENCE TOMOGRAPHY WITH ULTRAWIDE-FIELD IMAGING IN A DIABETIC RETINOPATHY TELEMEDICINE PROGRAM USING A SINGLE DEVICE.
Retina. 2023;43(11):1928–1935. PMID: 37871272